| View |
|
DR-XY29922
|
Cefalexin (as monohydrate)
|
Cepham
|
125mg/5mL
|
Powder For Suspension
|
Antibacterial (Cephalosporin)
|
New Myrex Laboratories Inc.
|
Philippines
|
Renewal
|
27 May 2024
|
30 August 2029
|
| View |
|
DR-XY29925
|
Loratadine
|
Allerta
|
10 mg
|
Tablet
|
Antihistamine
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 September 2022
|
29 September 2028
|
| View |
|
DR-XY2993
|
Atracurium Besylate
|
Tracrium
|
10mg/ mL
|
Solution for Injection (I.V.)
|
Neuromuscular blocker
|
GlaxoSmithKline Manufacturing S.p.A
|
Italy
|
Renewal
|
01 June 2021
|
01 August 2026
|
| View |
|
DR-XY29930
|
Lansoprazole
|
Pylison
|
30 mg
|
Capsule
|
Proton Pump Inhibitor
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
05 July 2022
|
01 September 2027
|
| View |
|
DR-XY29934
|
Levetiracetam
|
Keppra
|
250 mg
|
Film-Coated Tablet
|
Antiepileptics
|
UCB Pharma SA
|
Belgium
|
Automatic Renewal
|
28 September 2022
|
20 November 2027
|
| View |
|
DR-XY29935
|
Terazosin (as Hydrochloride Dihydrate)
|
Lotencin
|
2 mg
|
Tablet
|
Alpha-adrenoreceptor Antagonist
|
Daewon Pharm. Co., Ltd.
|
Korea
|
Renewal
|
27 April 2024
|
01 September 2029
|
| View |
|
DR-XY29955
|
Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Disudrin
|
5 mg/1 mg per 5 mL Syrup
|
Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
18 November 2021
|
16 March 2026
|
| View |
|
DR-XY29956
|
Ciprofloxacin (As Hydrochloride)
|
Bactinil
|
2 mg/ mL
|
Solution For IV Infusion
|
-
|
Unique Pharmaceutical Laboratories (A Division of
J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
-
|
27 May 2021
|
13 September 2026
|
| View |
|
DR-XY29985
|
Vitamin B1 + B6 + B12
|
Mintribee
|
100 mg/5 mg/50 mcg per 5 mL
|
Syrup
|
Vitamin
|
Lloyd Laboratories, Inc
|
Philippines
|
Renewal
|
15 June 2024
|
16 September 2029
|
| View |
|
DR-XY30030
|
Ibuprofen/Paracetamol
|
Flexigesic MPR Capsule
|
200 mg/325 mg
|
Capsule
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)/Analgesic/Antipyretic
|
Medi-Rx ,Inc.
|
Philippines
|
Renewal
|
25 June 2024
|
22 September 2029
|
| View |
|
DR-XY30034
|
Thiamine Mononitrate (Vitamin B1) / Pyridoxine Hydrochloride (Vitamin B6) / Cyanocobalamin (Vitamin B12) / Folic Acid
|
Meganerv FA
|
100mg/50mg/1.2mg/2.5mg
|
Tablet
|
Vitamis
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
06 August 2024
|
22 September 2029
|
| View |
|
DR-XY30037
|
Phenylpropanolamine Hydrochloride + Phenylephrine Hydrochloride + Brompheniramine Maleate
|
None
|
2.5 mg/2.5mg/2mg per 5 mL
|
Syrup (Oral drops)
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
15 October 2020
|
22 September 2025
|
| View |
|
DR-XY30043
|
dL-Alpha Tocopheryl Acetate (Vitamin E)
|
Myra 300-E
|
300 I.U.
|
Softgel Capsule
|
Vitamin
|
PT Darya- Varia Laboratoria, Tbk.
|
Indonesia
|
Renewal
|
16 June 2024
|
24 September 2029
|
| View |
|
DR-XY30064
|
Ciprofloxacin (as lactate)
|
BAXOLYN
|
2mg/ mL
|
Solution for Injection (IV)
|
Antibacterial (Quinolone)
|
Bosch Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
05 October 2021
|
29 September 2026
|
| View |
|
DR-XY30066
|
Clobetasol Propionate
|
Clobenate
|
500 mcg/g (0.05% w/w)
|
Topical Cream
|
Steroidal Anti-inflammatory/ Anti-pruritic
|
Micro Labs Limited
|
India
|
Renewal
|
29 September 2024
|
29 September 2029
|
| View |
|
DR-XY30076
|
Doxorubicin Hydrochloride
|
Dactorubin
|
10 mg
|
Lyopjilized Powder for Injection (IV)
|
-
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
-
|
03 February 2021
|
01 October 2026
|
| View |
|
DR-XY30077
|
Doxorubicin Hydrochloride
|
Dactorubin
|
50 mg
|
Lyopjilized Powder For Injection (Iv)
|
-
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
-
|
08 February 2021
|
01 October 2026
|
| View |
|
DR-XY30095
|
Nidcor
|
Metformin Hydrochloride
|
500 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
02 May 2026
|
| View |
|
DR-XY30121
|
Amlodipine (as besilate) + Atorvastatin (as calcium)
|
Norvasc Protect
|
5mg / 20mg
|
Tablet
|
Calcium Channel Blocker/ Lipid Regulating Agent
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Renewal
|
04 August 2024
|
30 September 2029
|
| View |
|
DR-XY30122
|
Amlodipine (as besilate) + Atorvastatin (as calcium)
|
Norvasc Protect
|
10mg / 20mg
|
Tablet
|
Calcium Channel Blocker/ Lipid Regulating Agent
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Renewal
|
08 September 2024
|
30 September 2029
|